Global Next-Generation Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities
The Next-Generation Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Next-Generation Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Next-Generation Biologics market.
Major players in the global Next-Generation Biologics market include:
Molecular Partners
Eli Lilly
Allergan
Roche
Pfizer
Kyowa Hakko Kirin
Sanofi
Novo Nordisk
Bayer
Biogen Idec
On the basis of types, the Next-Generation Biologics market is primarily split into:
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
On the basis of applications, the market covers:
Medical
Scientific Research
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Next-Generation Biologics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Next-Generation Biologics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Next-Generation Biologics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Next-Generation Biologics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Next-Generation Biologics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Next-Generation Biologics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Next-Generation Biologics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Next-Generation Biologics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Next-Generation Biologics market, including the global production and revenue forecast, regional forecast. It also foresees the Next-Generation Biologics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Next-Generation Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Next-Generation Biologics market.
Major players in the global Next-Generation Biologics market include:
Molecular Partners
Eli Lilly
Allergan
Roche
Pfizer
Kyowa Hakko Kirin
Sanofi
Novo Nordisk
Bayer
Biogen Idec
On the basis of types, the Next-Generation Biologics market is primarily split into:
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
On the basis of applications, the market covers:
Medical
Scientific Research
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Next-Generation Biologics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Next-Generation Biologics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Next-Generation Biologics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Next-Generation Biologics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Next-Generation Biologics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Next-Generation Biologics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Next-Generation Biologics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Next-Generation Biologics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Next-Generation Biologics market, including the global production and revenue forecast, regional forecast. It also foresees the Next-Generation Biologics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 NEXT-GENERATION BIOLOGICS MARKET OVERVIEW
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Next-Generation Biologics Segment by Type
1.2.1 Global Next-Generation Biologics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Antibodies
1.2.3 The Market Profile of Regenerative medicine
1.2.4 The Market Profile of Insulins
1.2.5 The Market Profile of Growth hormones
1.2.6 The Market Profile of Other
1.3 Global Next-Generation Biologics Segment by Application
1.3.1 Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Medical
1.3.3 The Market Profile of Scientific Research
1.3.4 The Market Profile of Other
1.4 Global Next-Generation Biologics Market by Region (2014-2026)
1.4.1 Global Next-Generation Biologics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3 Europe Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.2 UK Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.3 France Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.4 China Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.5 Japan Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.6 India Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Next-Generation Biologics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Next-Generation Biologics (2014-2026)
1.5.1 Global Next-Generation Biologics Revenue Status and Outlook (2014-2026)
1.5.2 Global Next-Generation Biologics Production Status and Outlook (2014-2026)
2 GLOBAL NEXT-GENERATION BIOLOGICS MARKET LANDSCAPE BY PLAYER
2.1 Global Next-Generation Biologics Production and Share by Player (2014-2019)
2.2 Global Next-Generation Biologics Revenue and Market Share by Player (2014-2019)
2.3 Global Next-Generation Biologics Average Price by Player (2014-2019)
2.4 Next-Generation Biologics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Next-Generation Biologics Market Competitive Situation and Trends
2.5.1 Next-Generation Biologics Market Concentration Rate
2.5.2 Next-Generation Biologics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Molecular Partners
3.1.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Next-Generation Biologics Product Profiles, Application and Specification
3.1.3 Molecular Partners Next-Generation Biologics Market Performance (2014-2019)
3.1.4 Molecular Partners Business Overview
3.2 Eli Lilly
3.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Next-Generation Biologics Product Profiles, Application and Specification
3.2.3 Eli Lilly Next-Generation Biologics Market Performance (2014-2019)
3.2.4 Eli Lilly Business Overview
3.3 Allergan
3.3.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Next-Generation Biologics Product Profiles, Application and Specification
3.3.3 Allergan Next-Generation Biologics Market Performance (2014-2019)
3.3.4 Allergan Business Overview
3.4 Roche
3.4.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Next-Generation Biologics Product Profiles, Application and Specification
3.4.3 Roche Next-Generation Biologics Market Performance (2014-2019)
3.4.4 Roche Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Next-Generation Biologics Product Profiles, Application and Specification
3.5.3 Pfizer Next-Generation Biologics Market Performance (2014-2019)
3.5.4 Pfizer Business Overview
3.6 Kyowa Hakko Kirin
3.6.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Next-Generation Biologics Product Profiles, Application and Specification
3.6.3 Kyowa Hakko Kirin Next-Generation Biologics Market Performance (2014-2019)
3.6.4 Kyowa Hakko Kirin Business Overview
3.7 Sanofi
3.7.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Next-Generation Biologics Product Profiles, Application and Specification
3.7.3 Sanofi Next-Generation Biologics Market Performance (2014-2019)
3.7.4 Sanofi Business Overview
3.8 Novo Nordisk
3.8.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Next-Generation Biologics Product Profiles, Application and Specification
3.8.3 Novo Nordisk Next-Generation Biologics Market Performance (2014-2019)
3.8.4 Novo Nordisk Business Overview
3.9 Bayer
3.9.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Next-Generation Biologics Product Profiles, Application and Specification
3.9.3 Bayer Next-Generation Biologics Market Performance (2014-2019)
3.9.4 Bayer Business Overview
3.10 Biogen Idec
3.10.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Next-Generation Biologics Product Profiles, Application and Specification
3.10.3 Biogen Idec Next-Generation Biologics Market Performance (2014-2019)
3.10.4 Biogen Idec Business Overview
4 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Next-Generation Biologics Production and Market Share by Type (2014-2019)
4.2 Global Next-Generation Biologics Revenue and Market Share by Type (2014-2019)
4.3 Global Next-Generation Biologics Price by Type (2014-2019)
4.4 Global Next-Generation Biologics Production Growth Rate by Type (2014-2019)
4.4.1 Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)
4.4.2 Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)
4.4.3 Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)
4.4.4 Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)
4.4.5 Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)
5 GLOBAL NEXT-GENERATION BIOLOGICS MARKET ANALYSIS BY APPLICATION
5.1 Global Next-Generation Biologics Consumption and Market Share by Application (2014-2019)
5.2 Global Next-Generation Biologics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Next-Generation Biologics Consumption Growth Rate of Medical (2014-2019)
5.2.2 Global Next-Generation Biologics Consumption Growth Rate of Scientific Research (2014-2019)
5.2.3 Global Next-Generation Biologics Consumption Growth Rate of Other (2014-2019)
6 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Next-Generation Biologics Consumption by Region (2014-2019)
6.2 United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.4 China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.6 India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Next-Generation Biologics Production and Market Share by Region (2014-2019)
7.2 Global Next-Generation Biologics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
8 NEXT-GENERATION BIOLOGICS MANUFACTURING ANALYSIS
8.1 Next-Generation Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Next-Generation Biologics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Next-Generation Biologics Industrial Chain Analysis
9.2 Raw Materials Sources of Next-Generation Biologics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Next-Generation Biologics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL NEXT-GENERATION BIOLOGICS MARKET FORECAST (2019-2026)
11.1 Global Next-Generation Biologics Production, Revenue Forecast (2019-2026)
11.1.1 Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Next-Generation Biologics Price and Trend Forecast (2019-2026)
11.2 Global Next-Generation Biologics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Next-Generation Biologics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Next-Generation Biologics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Next-Generation Biologics Segment by Type
1.2.1 Global Next-Generation Biologics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Antibodies
1.2.3 The Market Profile of Regenerative medicine
1.2.4 The Market Profile of Insulins
1.2.5 The Market Profile of Growth hormones
1.2.6 The Market Profile of Other
1.3 Global Next-Generation Biologics Segment by Application
1.3.1 Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Medical
1.3.3 The Market Profile of Scientific Research
1.3.4 The Market Profile of Other
1.4 Global Next-Generation Biologics Market by Region (2014-2026)
1.4.1 Global Next-Generation Biologics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3 Europe Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.2 UK Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.3 France Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.4 China Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.5 Japan Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.6 India Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Next-Generation Biologics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Next-Generation Biologics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Next-Generation Biologics (2014-2026)
1.5.1 Global Next-Generation Biologics Revenue Status and Outlook (2014-2026)
1.5.2 Global Next-Generation Biologics Production Status and Outlook (2014-2026)
2 GLOBAL NEXT-GENERATION BIOLOGICS MARKET LANDSCAPE BY PLAYER
2.1 Global Next-Generation Biologics Production and Share by Player (2014-2019)
2.2 Global Next-Generation Biologics Revenue and Market Share by Player (2014-2019)
2.3 Global Next-Generation Biologics Average Price by Player (2014-2019)
2.4 Next-Generation Biologics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Next-Generation Biologics Market Competitive Situation and Trends
2.5.1 Next-Generation Biologics Market Concentration Rate
2.5.2 Next-Generation Biologics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Molecular Partners
3.1.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Next-Generation Biologics Product Profiles, Application and Specification
3.1.3 Molecular Partners Next-Generation Biologics Market Performance (2014-2019)
3.1.4 Molecular Partners Business Overview
3.2 Eli Lilly
3.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Next-Generation Biologics Product Profiles, Application and Specification
3.2.3 Eli Lilly Next-Generation Biologics Market Performance (2014-2019)
3.2.4 Eli Lilly Business Overview
3.3 Allergan
3.3.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Next-Generation Biologics Product Profiles, Application and Specification
3.3.3 Allergan Next-Generation Biologics Market Performance (2014-2019)
3.3.4 Allergan Business Overview
3.4 Roche
3.4.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Next-Generation Biologics Product Profiles, Application and Specification
3.4.3 Roche Next-Generation Biologics Market Performance (2014-2019)
3.4.4 Roche Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Next-Generation Biologics Product Profiles, Application and Specification
3.5.3 Pfizer Next-Generation Biologics Market Performance (2014-2019)
3.5.4 Pfizer Business Overview
3.6 Kyowa Hakko Kirin
3.6.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Next-Generation Biologics Product Profiles, Application and Specification
3.6.3 Kyowa Hakko Kirin Next-Generation Biologics Market Performance (2014-2019)
3.6.4 Kyowa Hakko Kirin Business Overview
3.7 Sanofi
3.7.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Next-Generation Biologics Product Profiles, Application and Specification
3.7.3 Sanofi Next-Generation Biologics Market Performance (2014-2019)
3.7.4 Sanofi Business Overview
3.8 Novo Nordisk
3.8.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Next-Generation Biologics Product Profiles, Application and Specification
3.8.3 Novo Nordisk Next-Generation Biologics Market Performance (2014-2019)
3.8.4 Novo Nordisk Business Overview
3.9 Bayer
3.9.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Next-Generation Biologics Product Profiles, Application and Specification
3.9.3 Bayer Next-Generation Biologics Market Performance (2014-2019)
3.9.4 Bayer Business Overview
3.10 Biogen Idec
3.10.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Next-Generation Biologics Product Profiles, Application and Specification
3.10.3 Biogen Idec Next-Generation Biologics Market Performance (2014-2019)
3.10.4 Biogen Idec Business Overview
4 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Next-Generation Biologics Production and Market Share by Type (2014-2019)
4.2 Global Next-Generation Biologics Revenue and Market Share by Type (2014-2019)
4.3 Global Next-Generation Biologics Price by Type (2014-2019)
4.4 Global Next-Generation Biologics Production Growth Rate by Type (2014-2019)
4.4.1 Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)
4.4.2 Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)
4.4.3 Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)
4.4.4 Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)
4.4.5 Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)
5 GLOBAL NEXT-GENERATION BIOLOGICS MARKET ANALYSIS BY APPLICATION
5.1 Global Next-Generation Biologics Consumption and Market Share by Application (2014-2019)
5.2 Global Next-Generation Biologics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Next-Generation Biologics Consumption Growth Rate of Medical (2014-2019)
5.2.2 Global Next-Generation Biologics Consumption Growth Rate of Scientific Research (2014-2019)
5.2.3 Global Next-Generation Biologics Consumption Growth Rate of Other (2014-2019)
6 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Next-Generation Biologics Consumption by Region (2014-2019)
6.2 United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.4 China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.6 India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Next-Generation Biologics Production and Market Share by Region (2014-2019)
7.2 Global Next-Generation Biologics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)
8 NEXT-GENERATION BIOLOGICS MANUFACTURING ANALYSIS
8.1 Next-Generation Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Next-Generation Biologics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Next-Generation Biologics Industrial Chain Analysis
9.2 Raw Materials Sources of Next-Generation Biologics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Next-Generation Biologics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL NEXT-GENERATION BIOLOGICS MARKET FORECAST (2019-2026)
11.1 Global Next-Generation Biologics Production, Revenue Forecast (2019-2026)
11.1.1 Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Next-Generation Biologics Price and Trend Forecast (2019-2026)
11.2 Global Next-Generation Biologics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Next-Generation Biologics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Next-Generation Biologics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
